Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
J L
JL
Górriz
A
A
Sancho
J M
JM
Lopez-Martin
E
E
Alcoy
C
C
Catalán
L M
LM
Pallardó
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001639:Bicarbonates / Q000008:administration & dosage; D003922:Diabetes Mellitus, Type 1; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004231:Diuresis; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
D000806:Angiotensin-Converting Enzyme Inhibitors; D001639:Bicarbonates; D000960:Hypolipidemic Agents; D004656:Enalapril; D015248:Gemfibrozil